XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
OPERATING ACTIVITIES        
Net income (loss) $ 5,544,000 $ 9,937,000 $ 8,533,000 $ (6,683,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Gain on sales (2,841,000)   (2,942,000)  
Impairment charges       21,396,000
Straight-line rents and expenses, net     (249,000) (492,000)
Provision for doubtful accounts     231,000 1,002,000
Depreciation and amortization 10,346,000 10,541,000 20,475,000 20,595,000
Amortization of intangible lease liabilities, net (631,000) (2,213,000) (1,222,000) (2,882,000)
Expense relating to share-based compensation, net     2,043,000 1,837,000
Amortization of premium on mortgage loan payable       (65,000)
Amortization of deferred financing costs     651,000 596,000
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:        
Rents and other receivables     138,000 (1,895,000)
Prepaid expenses and other     1,239,000 (1,068,000)
Accounts payable and accrued liabilities     (505,000) (1,767,000)
Net cash provided by operating activities     28,392,000 30,574,000
INVESTING ACTIVITIES        
Acquisition of real estate     (9,083,000)  
Expenditures for real estate improvements     (15,174,000) (14,016,000)
Net proceeds from sales of real estate     18,651,000  
Net cash (used in) investing activities     (5,606,000) (14,016,000)
FINANCING ACTIVITIES        
Repayments under revolving credit facility     (16,000,000) (16,500,000)
Advances under revolving credit facility     15,000,000 66,000,000
Mortgage repayments     (508,000) (1,497,000)
Noncontrolling interests:        
Distributions to limited partners     (56,000) (34,000)
Redemptions of preferred stock       (50,016,000)
Common stock sales less issuance expenses, net     8,000 5,000
Common stock repurchases     (6,844,000)  
Preferred stock dividends     (5,376,000) (5,900,000)
Distributions to common shareholders     (8,906,000) (9,180,000)
Net cash (used in) financing activities     (22,682,000) (17,122,000)
Net increase (decrease) in cash, cash equivalents and restricted cash     104,000 (564,000)
Cash, cash equivalents and restricted cash at beginning of year     1,977,000 7,219,000
Cash, cash equivalents and restricted cash at end of period 2,081,000 6,655,000 2,081,000 6,655,000
Reconciliation to consolidated balance sheets:        
Cash and cash equivalents 2,081,000 1,625,000 2,081,000 1,625,000
Restricted cash   5,030,000   5,030,000
Cash, cash equivalents and restricted cash at end of period $ 2,081,000 $ 6,655,000 $ 2,081,000 $ 6,655,000